366 related articles for article (PubMed ID: 35246237)
21. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.
Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S
PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
Lamy M; Erickson CA
Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163
[TBL] [Abstract][Full Text] [Related]
23. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Epstein T; Patsopoulos NA; Weiser M
Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
[TBL] [Abstract][Full Text] [Related]
24. Effect of L-Carnosine in children with autism spectrum disorders: a systematic review and meta-analysis of randomised controlled trials.
Abraham DA; Undela K; Narasimhan U; Rajanandh MG
Amino Acids; 2021 Apr; 53(4):575-585. PubMed ID: 33704575
[TBL] [Abstract][Full Text] [Related]
25. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.
Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D
PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715
[TBL] [Abstract][Full Text] [Related]
26. Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study.
Lamberti M; Siracusano R; Italiano D; Alosi N; Cucinotta F; Di Rosa G; Germanò E; Spina E; Gagliano A
Paediatr Drugs; 2016 Aug; 18(4):319-29. PubMed ID: 27278054
[TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature.
Joshi G; Wilens T; Firmin ES; Hoskova B; Biederman J
J Psychopharmacol; 2021 Mar; 35(3):203-210. PubMed ID: 33349107
[TBL] [Abstract][Full Text] [Related]
28. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.
Fung LK; Mahajan R; Nozzolillo A; Bernal P; Krasner A; Jo B; Coury D; Whitaker A; Veenstra-Vanderweele J; Hardan AY
Pediatrics; 2016 Feb; 137 Suppl 2():S124-35. PubMed ID: 26908468
[TBL] [Abstract][Full Text] [Related]
30. Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
Handen BL; Aman MG; Arnold LE; Hyman SL; Tumuluru RV; Lecavalier L; Corbett-Dick P; Pan X; Hollway JA; Buchan-Page KA; Silverman LB; Brown NV; Rice RR; Hellings J; Mruzek DW; McAuliffe-Bellin S; Hurt EA; Ryan MM; Levato L; Smith T
J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):905-15. PubMed ID: 26506581
[TBL] [Abstract][Full Text] [Related]
31. Retracing our steps: A review on autism research in children, its limitation and impending pharmacological interventions.
Salloum-Asfar S; Zawia N; Abdulla SA
Pharmacol Ther; 2024 Jan; 253():108564. PubMed ID: 38008401
[TBL] [Abstract][Full Text] [Related]
32. Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews.
Fieiras C; Chen MH; Escobar Liquitay CM; Meza N; Rojas V; Franco JVA; Madrid E
BMJ Evid Based Med; 2023 Feb; 28(1):7-14. PubMed ID: 35101925
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Polyunsaturated Fatty Acids Supplementation in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials.
Händel MN; Rohde JF; Rimestad ML; Bandak E; Birkefoss K; Tendal B; Lemcke S; Callesen HE
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33917727
[TBL] [Abstract][Full Text] [Related]
34. ω-3 Fatty Acid Supplementation Does Not Affect Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis.
Horvath A; Łukasik J; Szajewska H
J Nutr; 2017 Mar; 147(3):367-376. PubMed ID: 28077731
[No Abstract] [Full Text] [Related]
35. The efficacy and safety in attention deficit hyperactivity disorder of second-generation antipsychotics and other medications for hyperactivity in children and adolescents with autism: a meta-analysis.
Wang F; Wen F; Yu L; Yan J; Liu J; Li Y; Cui Y
Int Clin Psychopharmacol; 2021 May; 36(3):109-116. PubMed ID: 33492013
[TBL] [Abstract][Full Text] [Related]
36. Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder.
Kilincaslan A; Mutluer TD; Pasabeyoglu B; Tutkunkardas MD; Mukaddes NM
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):798-806. PubMed ID: 27228116
[TBL] [Abstract][Full Text] [Related]
37. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
Castells X; Blanco-Silvente L; Cunill R
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
